High Antimicrobial Consumption, Low Reported Infection Rates: An Ecological Analysis of HAI Surveillance Discordance Across EU/EEA Countries
Open Access
- 17 July 2026
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 15 (7) , 700
Abstract
Background/Objectives: Healthcare-associated infections (HAI) affect an estimated 4.3 million patients annually in EU/EEA hospitals; yet, reported prevalence rates vary nearly fivefold across member states, a degree of variation inconsistent with clinical or epidemiological differences alone. Romania exemplifies this paradox: it records one of the lowest reported HAI prevalence rates in Europe while sustaining one of the highest antimicrobial consumption levels on the continent. This study examines whether antimicrobial consumption data can serve as a cross-check on reported HAI prevalence across EU/EEA countries and discusses implications for European funding mechanisms. Methods: A cross-sectional ecological analysis was conducted using data from 26 EU/EEA countries. HAI prevalence was extracted from the ECDC Point Prevalence Survey 2022–2023; antimicrobial consumption indicators from the ESAC-Net Annual Epidemiological Report 2023. Pearson and Spearman correlations, multiple linear regression with Cook’s distance diagnostics, bootstrap resampling, and k-means cluster analysis were performed. Variance inflation factors were computed to assess multicollinearity; community sector AMC was excluded from the final regression model due to near-perfect collinearity with total AMC. Results: No antimicrobial consumption indicator was significantly associated with reported HAI prevalence (total AMC: r = 0.274, p = 0.175; broad-spectrum hospital proportion: r = 0.082, p = 0.692); bootstrap confidence intervals confirmed the instability of all estimates. Romania and Bulgaria were identified as influential outliers whose consumption profiles are substantially inconsistent with their reported infection rates, with model-based estimates of 7.3% and 7.0% respectively against reported values of 3.1% and 3.7%. Cluster analysis placed both countries in an isolated group with the highest antimicrobial consumption and broad-spectrum hospital antibiotic use in the sample alongside the lowest reported HAI prevalence, a configuration not replicated elsewhere in the EU/EEA. Conclusions: The absence of a significant aggregate association between antimicrobial consumption and reported HAI prevalence, combined with the systematic identification of Romania and Bulgaria as influential observations whose consumption profiles are inconsistent with their reported infection rates, raises the hypothesis of surveillance underreporting as a plausible explanation, though the ecological design does not permit causal inference and alternative explanations, including differences in antimicrobial stewardship maturity and prescribing culture, cannot be excluded. Antimicrobial consumption indicators, particularly the proportion of broad-spectrum antibiotics in hospital use, may serve as a proxy for HAI burden where direct surveillance is incomplete, and their integration into European surveillance frameworks is warranted. These findings have direct policy relevance for the allocation of resources under EU4Health, EU-JAMRAI 2, and national recovery and resilience programmes, and support investment in surveillance reform as a precondition for effective infection prevention programmes.Keywords
This publication has 18 references indexed in Scilit:
- Rebound in community antibiotic consumption after the observed decrease during the COVID-19 pandemic, EU/EEA, 2022Eurosurveillance, 2023
- Impact of antimicrobial stewardship implementation on the antibiotic use and susceptibility in a Japanese long-term care hospitalJournal of Infection and Chemotherapy, 2023
- Impact of an antimicrobial stewardship in a 126-bed community hospital with close communication between pharmacists working on post-prescription audit, ward pharmacists, and the antimicrobial stewardship teamJournal of Pharmaceutical Health Care and Sciences, 2021
- Mortality attributable to hospital acquired infections with multidrug-resistant bacteria in a large group of German hospitalsJournal of Infection and Public Health, 2020
- Organization of control of nosocomial infections in Central Eastern European countriesWiener Medizinische Wochenschrift, 2019
- Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017Eurosurveillance, 2018
- Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050?PLOS Medicine, 2016
- Burden of Six Healthcare-Associated Infections on European Population Health: Estimating Incidence-Based Disability-Adjusted Life Years through a Population Prevalence-Based Modelling StudyPLOS Medicine, 2016
- Mortality and Hospital Stay Associated with Resistant Staphylococcus aureus and Escherichia coli Bacteremia: Estimating the Burden of Antibiotic Resistance in EuropePLOS Medicine, 2011
- Outpatient antibiotic use in Europe and association with resistance: a cross-national database studyThe Lancet, 2005